{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:34:01Z","timestamp":1782347641070,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,3,18]],"date-time":"2006-03-18T00:00:00Z","timestamp":1142640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,3,18]],"date-time":"2006-03-18T00:00:00Z","timestamp":1142640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s10067-005-0169-y","type":"journal-article","created":{"date-parts":[[2006,3,17]],"date-time":"2006-03-17T14:28:32Z","timestamp":1142605712000},"page":"578-581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Serious liver disease induced by infliximab"],"prefix":"10.1007","volume":"26","author":[{"given":"Gabriel J.","family":"Tobon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jose","family":"Jaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,18]]},"reference":[{"key":"169_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","volume":"30","author":"DM Knight","year":"1993","unstructured":"Knight DM, Trinh H, Le J et al (1993) Construction and initial characterization of a mouse\u2013human chimeric anti-TNF antibody. Mol Immunol 30:1443\u20131453","journal-title":"Mol Immunol"},{"key":"169_CR2","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Eng J Med 340:1398\u20131405","journal-title":"N Eng J Med"},{"key":"169_CR3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van de Heijde DMFM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Eng J Med 343:1594\u20131602","journal-title":"N Eng J Med"},{"key":"169_CR4","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3","volume":"44","author":"G Saleem","year":"2001","unstructured":"Saleem G, Li Shuan, MacPherson BR et al (2001) Hepatitis with interfase inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on article by Charles et al. Arthritis Rheum 44:1966\u20131968","journal-title":"Arthritis Rheum"},{"key":"169_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4065\/76.1.84","volume":"76","author":"V Menghini","year":"2001","unstructured":"Menghini V, Arora A (2001) Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc 76:84\u201386","journal-title":"Mayo Clin Proc"},{"key":"169_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/ard.2004.032821","volume":"64","author":"V Germano","year":"2005","unstructured":"Germano V, Picchianti Diamanti A, Baccano G, Natale E, Onetti Muda A, Priori R, Valesini G (2005) Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64:1519\u20131520","journal-title":"Ann Rheum Dis"},{"key":"169_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/ard.2003.006775","volume":"63","author":"M Feletar","year":"2004","unstructured":"Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD (2004) Treatment of refractory psoriatic arthritis with infliximab: a 12\u00a0month observational study of 16 patients. Ann Rheum Dis 63:156\u2013161","journal-title":"Ann Rheum Dis"},{"key":"169_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1600-0528.2002.017411.x","volume":"174","author":"AM Diehl","year":"2000","unstructured":"Diehl AM (2000) Cytokines regulation of liver injury and repair. Immunol Rev 174:160\u2013171","journal-title":"Immunol Rev"},{"key":"169_CR9","first-page":"2287","volume":"30","author":"S Jarret","year":"2003","unstructured":"Jarret S, Cunnane G, Conaghan P et al (2003) Anti-tumor necrosis factor-\u03b1 therapy-induced vasculitis: case series. J Rheumatol 30:2287\u20132291","journal-title":"J Rheumatol"},{"key":"169_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10067-002-0654-5","volume":"22","author":"M Debandt","year":"2003","unstructured":"Debandt M, Vittecoq O, Descamps V et al (2003) Anti-TNF-\u03b1- induced systemic lupus syndrome. Clin Rheumatol 22:56\u201361","journal-title":"Clin Rheumatol"},{"key":"169_CR11","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","volume":"44","author":"WH Robinson","year":"2001","unstructured":"Robinson WH, Genovese MC, Moreand LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alfa antagonism. Arthritis Rheum 44:1977\u20131983","journal-title":"Arthritis Rheum"},{"key":"169_CR12","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/1529-0131(200011)43:11<2606::AID-ANR31>3.0.CO;2-X","volume":"46","author":"BJ Bloom","year":"2000","unstructured":"Bloom BJ (2000) Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 46:2606\u20132608","journal-title":"Arthritis Rheum"},{"key":"169_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2230.2004.01471.x","volume":"29","author":"AJ Stratigos","year":"2004","unstructured":"Stratigos AJ, Antoniou C, Stamathioudaki S et al (2004) Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 29:150\u2013153","journal-title":"Clin Exp Dermatol"},{"key":"169_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/ard.62.9.908","volume":"62","author":"I Foeldvari","year":"2003","unstructured":"Foeldvari I, Kr\u00fcger E, Schneider T (2003) Acute, non-obstructive, sterile cholecystitis associated with etanercept and infliximab for the treatment of juvenile polyarticular rheumatoid arthritis. Ann Rheum Dis 62:908\u2013909","journal-title":"Ann Rheum Dis"},{"key":"169_CR15","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M","volume":"43","author":"DS Pisetsky","year":"2000","unstructured":"Pisetsky DS (2000) Tumor necrosis factor \u03b1 blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum 43:2381\u20132382","journal-title":"Arthritis Rheum"},{"key":"169_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.autrev.2003.09.003","volume":"3","author":"I Diamantis","year":"2004","unstructured":"Diamantis I, Boumpas DT (2004) Autoimmune hepatitis: evolving concepts. Autoimmun Rev 3:207\u2013214","journal-title":"Autoimmun Rev"},{"key":"169_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1568-9972(03)00017-X","volume":"2","author":"D Vergani","year":"2003","unstructured":"Vergani D, Mieli-Vergani G (2003) Autoimmune hepatitis. Autoimmun Rev 2:241\u2013247","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-005-0169-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0169-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:08:30Z","timestamp":1659110910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-005-0169-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,18]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0169-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,18]]},"assertion":[{"value":"20 May 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}